CT
LLY icon

Colonial Trust’s Eli Lilly LLY Stock Holding History

Colonial Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7M Sell
17,055
-349
-2% -$354K 2.13% 6
2025
Q4 		$18.7M Sell
17,404
-200
-1% -$191K 2.49% 4
2025
Q3 		$13.4M Buy
17,604
+94
+0.5% +$70K 1.81% 9
2025
Q2 		$13.6M Sell
17,510
-433
-2% -$336K 1.99% 5
2025
Q1 		$14.8M Sell
17,943
-193
-1% -$161K 2.3% 3
2024
Q4 		$14M Buy
18,136
+254
+1% +$210K 2.08% 3
2024
Q3 		$15.8M Buy
17,882
+262
+1% +$236K 2.44% 3
2024
Q2 		$16M Sell
17,620
-232
-1% -$186K 2.81% 3
2024
Q1 		$13.9M Sell
17,852
-655
-4% -$466K 2.6% 4
2023
Q4 		$10.8M Buy
18,507
+966
+6% +$564K 2.25% 3
2023
Q3 		$9.42M Sell
17,541
-1,460
-8% -$752K 2.33% 3
2023
Q2 		$8.91M Sell
19,001
-662
-3% -$278K 2.13% 4
2023
Q1 		$6.75M Sell
19,663
-341
-2% -$115K 1.72% 5
2022
Q4 		$7.32M Sell
20,004
-1,149
-5% -$407K 2% 6
2022
Q3 		$6.84M Buy
+21,153
New +$6.7M 2.18% 6

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Colonial Trust's LLY Position: Q1 2026 in Review

Colonial Trust reduced its Eli Lilly (LLY) stake by 2% in Q1 2026, selling an estimated $354K and leaving 17,055 shares worth $15.7M. The position accounts for 2.13% of the portfolio, ranked #6.

Colonial Trust first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $18.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Colonial Trust held 17,055 shares of Eli Lilly worth $15.7M as of Q1 2026.
  • Colonial Trust sold 349 Eli Lilly shares in Q1 2026, an estimated $354K.
  • Eli Lilly made up 2.13% of Colonial Trust's portfolio in Q1 2026, its #6 holding.
  • Colonial Trust first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Colonial Trust's Eli Lilly position peaked at $18.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.